Optimizing Stroke and Bleeding Risk Assessment in Patients with Atrial Fibrillation: A Balance of Evidence, Practicality and Precision

Thromb Haemost. 2018 Dec;118(12):2014-2017. doi: 10.1055/s-0038-1676074. Epub 2018 Nov 20.

Authors

Marco Proietti^{1

2}, Nebojsa Mujovic^{3

4}, Tatjana S Potpara^{3

4}

Affiliations

¹ Istituto di Ricerche Farmacologiche "Mario Negri" IRCCS, Milan, Italy.
² Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy.
³ School of Medicine, University of Belgrade, Belgrade, Serbia.
⁴ Cardiology Clinic, Clinical Centre of Serbia, University of Belgrade, Belgrade, Serbia.

PMID: 30458556
DOI: 10.1055/s-0038-1676074

No abstract available

Georg Thieme Verlag KG Stuttgart · New York.

Publication types

Editorial

MeSH terms

Administration, Oral
Anticoagulants / therapeutic use*
Atrial Fibrillation / drug therapy*
Atrial Fibrillation / epidemiology
Evidence-Based Medicine
Hemorrhage / epidemiology*
Humans
Practice Guidelines as Topic
Risk
Risk Assessment
Stroke / epidemiology*

Substances

Anticoagulants